Loading...

News

Arkstone Launches Innovative Clinical Study to Evaluate OneChoice Report’s Impact on Antimicrobial Prescribing, Stewardship, and Patient Outcomes

Arkstone Launches Innovative Clinical Study to Evaluate OneChoice Report’s Impact on Antimicrobial Prescribing, Stewardship, and Patient Outcomes

Arkstone is excited to embark on a groundbreaking clinical study in collaboration with Laboratorio Clínico Roe in Peru. This study will explore the transformative capabilities of Arkstone's OneChoice Report, aiming to optimize the judicious use of antibiotic treatments for patients with bacteremia or bloodstream infections.
Read More
Arkstone Medical Solutions Launches Breakthrough OneChoice Report for Microbiology Lab Results

Arkstone Medical Solutions Launches Breakthrough OneChoice Report for Microbiology Lab Results

Building on the success of its molecular lab results OneChoice report, which has already benefited hundreds of thousands of patients and is trusted by thousands of healthcare providers, Arkstone now extends its revolutionary technology to the wider realm of microbiology.
Read More
Arkstone Introduces Interpretations of Skin Scrapings and Epidermal Samples

Arkstone Introduces Interpretations of Skin Scrapings and Epidermal Samples

OneChoice now includes interpretations of laboratory data taken via skin scrapings and epidermal samples. This advancement revolutionizes the management of superficial infections with a focus on topical antibiotic treatment.
Read More
Arkstone Medical Solutions and Dendi Announce Strategic Partnership

Arkstone Medical Solutions and Dendi Announce Strategic Partnership

The partnership between Arkstone Medical Solutions and Dendi represents a significant step forward in providing healthcare providers with the tools and technologies they need to make informed clinical decisions.
Read More
Arkstone’s Treatment Recommendations Now Include Realtime National Institutes of Health (NIH) Data

Arkstone’s Treatment Recommendations Now Include Realtime National Institutes of Health (NIH) Data

The NIH has been collecting lab result isolate data for decades, compiling information about the prevalence of antimicrobial resistance genes in specific organisms.
Read More
Arkstone’s OneChoice Treatment Recommendations Now Include Renal and Hepatic Reference Adjustments

Arkstone’s OneChoice Treatment Recommendations Now Include Renal and Hepatic Reference Adjustments

Now, providers have access to detailed and dynamic renal and hepatic dosing adjustments for any treatment recommendations provided.
Read More
Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix

Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix

Many healthcare providers treating infections in a pregnant patient have difficulty finding the best treatment, while also taking into consideration an antimicrobial that will have the lowest risk to the fetus.
Read More
Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations

Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations

Ovation LIMS/LIS enables prominent molecular diagnostic laboratories to provide comprehensive test results to thousands of clinicians nationwide. Now, these labs can deliver the Arkstone OneChoice report combined with the patient’s detected pathogens and antibiotic resistance genes outlined in the infectious disease laboratory results.
Read More